In particular, the subanalysis also revealed that an elevated GATA3 mRNA expression was related to a longer RFS time in the PR-positive patients (patients = 589, HR = 0.67, 95% CI: 0.47–0.95, p = 0.025, Fig. 6C) and the w/o lymph node metastasis group (Fig. 6H,I). Here, GATA3 is linked to metastatic malignant neoplasm in the lymph nodes.